rs137854615
|
|
|
0.030 |
GeneticVariation |
BEFREE |
We report the analysis of two novel mutations on the same codon, Y1795C (LQT-3) and Y1795H (BrS), expressed in HEK 293 cells and characterized using whole-cell patch clamp procedures.
|
11410597 |
2001 |
rs199473083
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Previously, the R282H-SCN5A mutation in the sodium channel gene was identified in patients with Brugada syndrome.
|
16864729 |
2006 |
rs199473083
|
|
|
0.030 |
GeneticVariation |
BEFREE |
We previously reported that the function of a trafficking-deficient BrS Na(v)1.5 mutation, R282H, could be restored by coexpression with the sodium channel polymorphism H558R.
|
21840964 |
2011 |
rs199473083
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The electrophysiological characteristics of the R282H channel are suggested to be closely related to the clinical phenotype of Brugada syndrome.
|
15828879 |
2005 |
rs199473574
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Characterization of a novel Nav1.5 channel mutation, A551T, associated with Brugada syndrome.
|
19706159 |
2009 |
rs199473574
|
|
|
0.030 |
GeneticVariation |
BEFREE |
We also identified the SCN5A A551T mutation in 1 of the 28 patients with Brugada syndrome.
|
16155735 |
2005 |
rs199473574
|
|
|
0.030 |
GeneticVariation |
BEFREE |
SCN5A genetic variants were identified in 14 of the 47 patients with BrS and four of the 14 patients with BrS had missense mutations (1651 G>A, 1776 C>G, 3578 G>A).
|
26154754 |
2015 |
rs41261344
|
|
|
0.030 |
GeneticVariation |
BEFREE |
SCN5A(R1193Q) is often identified in patients with type 3 long QT syndrome and Brugada syndrome.
|
30419068 |
2018 |
rs41261344
|
|
|
0.030 |
GeneticVariation |
BEFREE |
DNA analysis revealed a missense mutation (R1193Q) in the SCN5A gene, previously linked with familial sudden unexpected nocturnal death syndrome, also known as Brugada syndrome.
|
15851440 |
2005 |
rs41261344
|
|
|
0.030 |
GeneticVariation |
BEFREE |
<b>Conclusion:</b> A common SCN5A polymorphism R1193Q enhances UDB by propafenone and predisposes the patients to drug-induced BrS with PIP treatment.
|
30984031 |
2019 |
rs878855292
|
|
|
0.030 |
GeneticVariation |
BEFREE |
An R1632C variant in the SCN5A gene causing Brugada syndrome.
|
27082542 |
2016 |
rs878855292
|
|
|
0.030 |
GeneticVariation |
BEFREE |
Our genetic screening of SCN5A in 65 consecutive BrS probands revealed two patients with overlapping phenotypes: one carried an SCN5A R1632C (in domain IV-segment 4), which we have previously reported, the other carried a novel SCN5A N1541D (in domain IV-segment 1).
|
30935997 |
2019 |
rs878855292
|
|
|
0.030 |
GeneticVariation |
BEFREE |
A novel SCN5A R1632C mutation, located in the domain IV-segment 4 voltage sensor, was identified in a young male patient who had a syncopal episode during exercise and presented with atrial tachycardia, sinus node dysfunction, and Brugada syndrome.
|
26031372 |
2015 |
rs1060499900
|
|
|
0.020 |
GeneticVariation |
BEFREE |
p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient.
|
23085483 |
2013 |
rs1060499900
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Thus, the mutant‑induced changes contributed to the loss of function of Nav1.5 channels, which indicates that the p.D1690N variant may have a pathogenic role in BrS.
|
27108952 |
2016 |
rs137854602
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The R1512W mutation found in our first patient diagnosed with Brugada syndrome produced a slowing of both inactivation and recovery from inactivation.
|
10727653 |
2000 |
rs137854602
|
|
|
0.020 |
GeneticVariation |
BEFREE |
This initial functional study for SCN5A mutation in the Chinese SUNDS victim revealed that the acidosis aggravated the loss of function of mutant channel R1512W and suggested that nocturnal sleep disorders-associated slight acidosis may trigger the lethal arrhythmia underlying the sudden death of SUNDS cases in the setting of genetic defect.
|
27281089 |
2016 |
rs199473096
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The clinical presentation of patients carrying the T353I mutation is that of Brugada syndrome and could be explained by a cardiac Na(+) channel trafficking defect.
|
17198989 |
2007 |
rs199473096
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine.
|
25261036 |
2015 |
rs199473568
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Molecular genetic studies of a patient with Brugada syndrome identified a novel mutation in SCN5A, which causes substitution of serine for asparagine (N406S) in S6 of domain I (IS6).
|
15877619 |
2005 |
rs199473568
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We demonstrate that lidocaine may suppress Brugada syndrome associated with the N406S mutation by preventing the sodium channel from accumulating in the intermediate inactivation state.
|
17445919 |
2007 |
rs199473625
|
|
|
0.020 |
GeneticVariation |
BEFREE |
Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome.
|
17075016 |
2006 |
rs199473625
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We describe a family harboring 2 SCN5A mutations: the ΔKPQ mutation, the "classical" gain-of-function mutation associated with Long-QT syndrome, and the I1660V mutation, a loss-of-function mutation associated with Brugada syndrome.
|
20812931 |
2011 |
rs1237724419
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The W1191X mutation is associated with BS and resulted in the loss of function of the cardiac sodium channel.
|
17141278 |
2007 |
rs137854613
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Readthrough of SCN5A Nonsense Mutations p.R1623X and p.S1812X Questions Gene-therapy in Brugada Syndrome.
|
28552050 |
2017 |